1.02CNY
3.77 BCNY
259.56 BCNY
910.40 M
About SHANGHAI PHARMACEUTICALS HOLDING
Sector
Headquarters
Shanghai
Employees (FY)
48.16 K
Website
Founded
1994
ISIN
CNE000000C82
FIGI
BBG000BKDQG3
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 601607 is 17.79 CNY — it has increased by 1.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI PHARMACEUTICALS HOLDING stocks are traded under the ticker 601607.
SHANGHAI PHARMACEUTICALS HOLDING is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
601607 stock is 2.41% volatile and has beta coefficient of 0.74. Check out the list of the most volatile stocks — is SHANGHAI PHARMACEUTICALS HOLDING there?
One year price forecast for SHANGHAI PHARMACEUTICALS HOLDING has a max estimate of 26.40 CNY and a min estimate of 12.40 CNY.
601607 earnings for the last quarter are 0.32 CNY per share, whereas the estimation was 0.41 CNY resulting in a −20.99% surprise. The estimated earnings for the next quarter are 0.52 CNY per share. See more details about SHANGHAI PHARMACEUTICALS HOLDING earnings.
SHANGHAI PHARMACEUTICALS HOLDING revenue for the last quarter amounts to 64.92 B CNY despite the estimated figure of 70.46 B CNY. In the next quarter revenue is expected to reach 62.85 B CNY.
Yes, you can track SHANGHAI PHARMACEUTICALS HOLDING financials in yearly and quarterly reports right on TradingView.
601607 stock has risen by 6.02% compared to the previous week, the month change is a 2.42% rise, over the last year SHANGHAI PHARMACEUTICALS HOLDING has showed a 20.01% decrease.
601607 net income for the last quarter is −28.77 M CNY, while the quarter before that showed 1.19 B CNY of net income which accounts for −102.42% change. Track more SHANGHAI PHARMACEUTICALS HOLDING financial stats to get the full picture.
Today SHANGHAI PHARMACEUTICALS HOLDING has the market capitalization of 64.73 B, it has decreased by 4.48% over the last week.
Yes, 601607 dividends are paid annually. The last dividend per share was 0.61 CNY. As of today, Dividend Yield (TTM)% is 3.49%. Tracking SHANGHAI PHARMACEUTICALS HOLDING dividends might help you take more informed decisions.
SHANGHAI PHARMACEUTICALS HOLDING dividend yield was 2.22% in 2023, and payout ratio reached 36.45%. The year before the numbers were 3.20% and 35.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 601607 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI PHARMACEUTICALS HOLDING stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 48.16 K employees. See our rating of the largest employees — is SHANGHAI PHARMACEUTICALS HOLDING on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI PHARMACEUTICALS HOLDING technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI PHARMACEUTICALS HOLDING stock shows the sell signal. See more of SHANGHAI PHARMACEUTICALS HOLDING technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHANGHAI PHARMACEUTICALS HOLDING future price: according to them, 601607 price has a max estimate of 26.40 CNY and a min estimate of 12.40 CNY. Read a more detailed SHANGHAI PHARMACEUTICALS HOLDING forecast: see what analysts think of SHANGHAI PHARMACEUTICALS HOLDING and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI PHARMACEUTICALS HOLDING EBITDA is 10.30 B CNY, and current EBITDA margin is 4.07%. See more stats in SHANGHAI PHARMACEUTICALS HOLDING financial statements.